SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-121 Cr | ₹41 Cr | ₹95 Cr | ₹70 Cr | ₹49 Cr |
What is the latest Consolidated Net Profit of SEQUENT SCIENTIFIC ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-121 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹95 Cr |
Mar2021 | ₹70 Cr |
Mar2020 | ₹49 Cr |
How is Consolidated Net Profit of SEQUENT SCIENTIFIC Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-121 Cr | Negative | |
Mar2023 | ₹41 Cr | -57.09 | |
Mar2022 | ₹95 Cr | 36.53 | |
Mar2021 | ₹70 Cr | 43.66 | |
Mar2020 | ₹49 Cr | - |
Compare Consolidated Net Profit of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,273.9 Cr | -8.4% | -14.9% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -3% | 5.6% | 9.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | 1% | 2.7% | 70.3% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -2.7% | 0.4% | -0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | 0.1% | 7.2% | 25.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -3.1% | -0.2% | -6.2% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -8.4% |
-14.9% |
14.5% |
SENSEX | 1.7% |
3.1% |
6.8% |
You may also like the below Video Courses